Human Menopausal Gonadotropin - hMG



Data Sheet
Home > hormones > Human Menopausal Gonadotropin - hMG

Human Menopausal Gonadotropin - hMG

Description: hMG is produced from a sterile preparation of placental glucoprotein urine of post-menopausal women. The hMG is purified by proprietary chromatographic techniques.
Source: Urine of post-menopausal women
Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation: The hMG was lyophilized from a concentrated (1mg/ml) solution with no additives.
Solubility: It is recommended to reconstitute the lyophilized hMG in sterile 18M-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.
Stability: Lyophilized hMG although stable at room temperature for 3 weeks, should be stored desiccated below -18 C. Upon reconstitution hMG should be stored at 4 C between 2-7 days and for future use below -18 C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
Purity: Greater than 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Anion-exchange FPLC. (c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
Biological Activity: ProSpec's hMG conforms the following activities: 100IU/mg of FSH and 100IU/mg LH.
Contaminents: Free of: HbsAg, Hepatitis B surface antigen and Hormones to HIV, Hepatitis C and HIV.
Protein content: Protein quantitation was carried out by two independent methods: UV spectroscopy at 280 nm.Analysis by RP-HPLC, using a calibrated solution of hMG as a Reference Standard.
Usage: This material is offered for research, laboratory or further manufacturing purposes.